CRISPR/Cas9-targeting of CD40 in hematopoietic stem cells limits immune activation mediated by anti-CD40

PloS One
Rui WangJijie Gu

Abstract

Inflammatory bowel diseases (IBD) are complex, multifactorial disorders characterized by chronic relapsing intestinal inflammation. IBD is diagnosed around 1 in 1000 individuals in Western countries with globally increasing incident rates. Association studies have identified hundreds of genes that are linked to IBD and potentially regulate its pathology. The further dissection of the genetic network underlining IBD pathogenesis and pathophysiology is hindered by the limited capacity to functionally characterize each genetic association, including generating knockout animal models for every associated gene. Cutting-edge CRISPR/Cas9-based technology may transform the field of IBD research by efficiently and effectively introducing genetic alterations. In the present study, we used CRISPR/Cas9-based technologies to genetically modify hematopoietic stem cells. Through cell sorting and bone marrow transplantation, we established a system to knock out target gene expression by over 90% in the immune system of reconstituted animals. Using a CD40-mediated colitis model, we further validated our CRISPR/Cas9-based platform for investigating gene function in experimental IBD. In doing so, we developed a model system that delivers genetica...Continue Reading

References

Apr 5, 2007·Nature Protocols·C BeckerM F Neurath
Aug 6, 2008·Methods in Molecular Biology·Jessamyn BagleyJohn Iacomini
Oct 3, 2008·PLoS Medicine·Ludvig M Sollid, Finn-Eirik Johansen
Dec 6, 2011·Progress in Molecular Biology and Translational Science·Atsushi Mizoguchi
Oct 26, 2013·Nature Protocols·F Ann RanFeng Zhang
Jan 22, 2014·The Journal of Experimental Medicine·Joseph Y ShinChristopher Y Park
Apr 1, 2014·Nature Biotechnology·Hao YinDaniel G Anderson
Sep 30, 2014·Cell·Randall J PlattFeng Zhang
Oct 20, 2014·Nature Biotechnology·Lukasz SwiechFeng Zhang
Dec 31, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jernej GodecW Nicholas Haining
May 23, 2015·Cellular and Molecular Gastroenterology and Hepatology·Patricia KieslerWarren Strober
Oct 4, 2015·Trends in Molecular Medicine·Lukas E Dow
Nov 4, 2015·Frontiers in Immunology·Nezha SenhajiYounes Zaid
Nov 13, 2015·Gut Pathogens·Janelle A JiminezRichard R E Uwiera
Nov 3, 2016·Proceedings of the National Academy of Sciences of the United States of America·Van Trung ChuKlaus Rajewsky
Dec 23, 2016·Nature Reviews. Drug Discovery·Christof FellmannJacob E Corn
Aug 2, 2017·Trends in Genetics : TIG·Holm H Uhlig, Aleixo M Muise
Aug 23, 2017·Disease-a-month : DM·Mahesh GajendranJana G Hashash
Sep 13, 2017·Hematology/oncology Clinics of North America·Maximilian RichterAndré Lieber
Feb 8, 2018·European Journal of Immunology·Katharina HochheiserMarco J Herold
Apr 21, 2018·Annual Review of Immunology·Holm H Uhlig, Fiona Powrie
Apr 12, 2019·Nature Communications·Martin W LaFleurArlene H Sharpe
May 31, 2019·World Journal of Gastroenterology : WJG·Viktor LimanskiyDinesh Vyas

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
genetic modification
Assay
FACS
flow cytometry
gene knockout

Software Mentioned

GraphPad Prism
Visiopharm
GraphPad

Related Concepts

Related Feeds

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.